Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
10000 participants
OBSERVATIONAL
2020-06-16
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To learn more, go to https://www.mirohealth.com/consent/
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Do EEG and Neurocognitive Assessments Correlate With COVID Brainfog Symptoms?
NCT05303116
COVID-19 Brain Injury
NCT04496076
NeuroCovid - a Study of Intensive Care-requiring Covid-19 Patients
NCT04578197
PET Imaging of Cyclooxygenase-1 in Participants With Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
NCT06920628
Exploring Brain Damages After COVID-19 Infection
NCT04405986
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
At the conclusion of the study, you will receive non-medical information on your brain function as well as study findings and publications made possible by your participation. With your permission, Miro Health can also release the results of your assessment to your physician. In order for Miro Health to do this, you will be required to confirm your identity online, sign a HIPAA agreement to share the information with your physician, and to enter your physician's name, email, and contact information. Study duration will depend on the development of the COVID-19 pandemic.
To participate, you must submit a valid email. No other personally identifiable information will be gathered at this time.
To participate, you will:
Answer online questions Answer a few questions about your health Download the Miro Health app from the iTunes store Open the app and complete Miro's interactive tasks (30 mins)
Advisory: Should you feel that you have symptoms related to COVID-19, contact your healthcare provider or local community health office. Miro Health cannot provide healthcare assistance.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Access to an iPad bought in 2013 or later
* Access to stable Wi-Fi
* Access to iTunes
Exclusion Criteria
* Preexisting neurological, psychiatric, or developmental disorder
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johns Hopkins University
OTHER
University of Pittsburgh
OTHER
Miro Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Natasha Belfor, PhD
Role: PRINCIPAL_INVESTIGATOR
Miro Health
Leah Rubin, PhD
Role: PRINCIPAL_INVESTIGATOR
Johns Hopkins University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Miro Health
San Francisco, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Related Links
Access external resources that provide additional context or updates about the study.
Asadi-Pooya \& Simani 2020; Leonardi et al., 2020, Wu et al., 2020
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MIRO_001_2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.